HARLAND JOHN H CO
SC TO-T, EX-99.(A)(9), 2000-07-21
BLANKBOOKS, LOOSELEAF BINDERS & BOOKBINDG & RELATD WORK
Previous: HARLAND JOHN H CO, SC TO-T, EX-99.(A)(8), 2000-07-21
Next: HARLAND JOHN H CO, 8-K, 2000-07-21



<PAGE>   1

                                                                  EXHIBIT (A)(9)

FOR MORE INFORMATION, CONTACT:

INVESTORS
Victoria P. Weyand, Vice President of Communications
770-593-5127
[email protected]

MEDIA
John Pensec, Director of Corporate Communications
770-593-5443
[email protected]

                         HARLAND LAUNCHES TENDER OFFER
                          FOR CONCENTREX INCORPORATED

     ATLANTA (JULY 21, 2000 -- John H. Harland Company (NYSE:JH) today announced
that its wholly owned subsidiary has commenced a previously announced tender
offer for all the outstanding shares of common stock of Concentrex Incorporated
at $7.00 per share, net to the seller, in cash. The tender offer is being made
pursuant to an Agreement and Plan of Merger, dated as of July 17, 2000. The
tender offer will expire at 12:00 midnight, New York City time, on Friday,
August 18, 2000, unless extended. The offer is conditioned upon, among other
things, there being validly tendered and not withdrawn a number of shares which
equals at least a majority of the outstanding shares of Concentrex on a fully
diluted basis. ChaseMellon Shareholder Services, L.L.C. is the Depositary for
the tender offer and Georgeson Shareholder Communications Inc. is the
Information Agent.
                             ---------------------

     This announcement is neither an offer to purchase nor a solicitation of an
offer to sell shares of Concentrex Incorporated. Harland is filing a tender
offer statement today with the Securities and Exchange Commission (SEC) and
Concentrex is filing a solicitation/recommendation statement with respect to the
offer. Concentrex shareholders are advised to read the tender offer statement
regarding the acquisition of Concentrex referenced in this press release, and
the related solicitation/recommendation statement. The tender offer statement
(including an offer to purchase, letter of transmittal and related tender
documents) and the solicitation/recommendation statement contain important
information which should be read carefully before any decision is made with
respect to the offer. These documents will be made available to all stockholders
of Concentrex at no expense to them. These documents will also be available at
no charge on the SEC's web site at www.sec.gov.

ABOUT HARLAND

     Atlanta-based John H. Harland Company (www.harland.net) is listed on the
New York Stock Exchange under the symbol "JH." Harland is a leading provider of
checks, financial software and direct marketing to the financial institution
market. Scantron Corporation (www.scantron.com), a wholly owned subsidiary, is a
leading provider of software services and systems for the collection, management
and interpretation of data to the financial, commercial and educational markets.

ABOUT CONCENTREX INCORPORATED

     Concentrex Incorporated, based in Portland, Oregon, is a leading provider
of technology-powered solutions to deliver financial services, including a broad
range of traditional software and services integrated with leading e-commerce
solutions that already enable its customers to serve more than 1 million home
banking customers. Concentrex serves over 5,500 financial institutions of all
types and sizes in the United States. Concentrex has major offices in 11
additional cities across the country. Its World Wide Web site is
www.concentrex.com.

     This press release contains statements which may constitute
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements include statements regarding the
intent, belief or
<PAGE>   2

current expectations of John H. Harland Company, Concentrex Incorporated and
members of their respective management, as well as the assumptions on which such
statements are based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance and involve
risks and uncertainties and that actual results may differ materially from those
contemplated by such forward-looking statements. Reference is made to the Risk
Factors and Cautionary Statements of Harland's Form 10-K and Form 10-Q and to
Concentrex's Securities and Exchange Commission reports filed under the
Securities Exchange Act.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission